Skip to main content
Have a personal or library account? Click to login
Do we use methylation of NFATC1 and FOS genes as a biomarker for postmenopausal osteoporosis? Cover

Do we use methylation of NFATC1 and FOS genes as a biomarker for postmenopausal osteoporosis?

Balkan Journal of Medical Genetics
Volume 23 (2020): Issue 2 (November 2020)
By:  and    
Open Access
|Mar 2021
Articles in this issue
DOI: https://doi.org/10.2478/bjmg-2020-0021 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Journal RSS Feed
Language: English
Page range: 35 - 40
Published on: Mar 23, 2021
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
FOS,
NFATC1,
Methylation sensitive-high resolution melting (MS-HRM),
Methylation,
Postmenopause,
Premenopause
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2021 R Kalkan, O Tosun, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 23 (2020): Issue 2 (November 2020)
Previous article
Next article